Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Dennis Gürgen"'
Autor:
Ola Al-Diab, Christin Sünkel, Eric Blanc, Rusan Ali Catar, Muhammad Imtiaz Ashraf, Hongfan Zhao, Pinchao Wang, Markus M. Rinschen, Raphaela Fritsche-Guenther, Florian Grahammer, Sebastian Bachmann, Dieter Beule, Jennifer A. Kirwan, Nikolaus Rajewsky, Tobias B. Huber, Dennis Gürgen, Angelika Kusch
Publikováno v:
Biology of Sex Differences, Vol 15, Iss 1, Pp 1-24 (2024)
Abstract Background Sex differences exist in the prevalence and progression of major glomerular diseases. Podocytes are the essential cell-type in the kidney which maintain the physiological blood-urine barrier, and pathological changes in podocyte h
Externí odkaz:
https://doaj.org/article/6486c593796f4fa4bf8ff685f8544f3b
Autor:
Heathcliff Dorado García, Fabian Pusch, Yi Bei, Jennifer von Stebut, Glorymar Ibáñez, Kristina Guillan, Koshi Imami, Dennis Gürgen, Jana Rolff, Konstantin Helmsauer, Stephanie Meyer-Liesener, Natalie Timme, Victor Bardinet, Rocío Chamorro González, Ian C. MacArthur, Celine Y. Chen, Joachim Schulz, Antje M. Wengner, Christian Furth, Birgit Lala, Angelika Eggert, Georg Seifert, Patrick Hundsoerfer, Marieluise Kirchner, Philipp Mertins, Matthias Selbach, Andrej Lissat, Frank Dubois, David Horst, Johannes H. Schulte, Simone Spuler, Daoqi You, Filemon Dela Cruz, Andrew L. Kung, Kerstin Haase, Michela DiVirgilio, Monika Scheer, Michael V. Ortiz, Anton G. Henssen
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-15 (2022)
Alveolar rhabdomyosarcoma is a clinically challenging disease due to the lack of druggable targets. Here the authors show preclinical evidence for ATR inhibitors as a therapeutic option for alveolar rhabdomyosarcoma.
Externí odkaz:
https://doaj.org/article/7544d8ec795c4dae8babbe7a0a303edd
Autor:
Dennis Gürgen, Theresia Conrad, Michael Becker, Susanne Sebens, Christoph Röcken, Jens Hoffmann, Stefan Langhammer
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-10 (2022)
The identification of novel therapeutic strategies for advanced non-small cell lung cancer (NSCLC) is essential as the outcome of most of these patients is poor. Here the authors provide a proof-of concept that specific low-dose drug combinations can
Externí odkaz:
https://doaj.org/article/92f28987a8ba465c999b6d45aa1fdeb2
Autor:
Oxana Schmidt, Nadja Nehls, Carolin Prexler, Kristina von Heyking, Tanja Groll, Katharina Pardon, Heathcliff D. Garcia, Tim Hensel, Dennis Gürgen, Anton G. Henssen, Angelika Eggert, Katja Steiger, Stefan Burdach, Günther H. S. Richter
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-16 (2021)
Abstract Background Histone acetylation and deacetylation seem processes involved in the pathogenesis of Ewing sarcoma (EwS). Here histone deacetylases (HDAC) class I were investigated. Methods Their role was determined using different inhibitors inc
Externí odkaz:
https://doaj.org/article/37a514c7436446fcbab46189c911acc5
Autor:
Oxana Schmidt, Nadja Nehls, Carolin Prexler, Kristina von Heyking, Tanja Groll, Katharina Pardon, Heathcliff D. Garcia, Tim Hensel, Dennis Gürgen, Anton G. Henssen, Angelika Eggert, Katja Steiger, Stefan Burdach, Günther H. S. Richter
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-3 (2022)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/e2b35416a024402dba01b1542821c08e
Autor:
Dennis Gürgen, Michael Becker, Mathias Dahlmann, Susanne Flechsig, Elke Schaeffeler, Florian A. Büttner, Christian Schmees, Regina Bohnert, Jens Bedke, Matthias Schwab, Johann J. Wendler, Martin Schostak, Burkhard Jandrig, Wolfgang Walther, Jens Hoffmann
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Renal cell carcinoma (RCC) is a kidney cancer with an onset mainly during the sixth or seventh decade of the patient’s life. Patients with advanced, metastasized RCC have a poor prognosis. The majority of patients develop treatment resistance towar
Externí odkaz:
https://doaj.org/article/7ac4640177bd4ea9bb1cc13c5cadf092
Autor:
Ye Zhu, Maximilian Blum, Uwe Hoff, Tim Wesser, Mandy Fechner, Christina Westphal, Dennis Gürgen, Rusan Ali Catar, Aurelie Philippe, Kaiyin Wu, Gordana Bubalo, Michael Rothe, Steven M Weldon, Duska Dragun, Wolf-Hagen Schunck
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0145645 (2016)
AIM:20-hydroxyeicosatetraenoic acid (20-HETE) and epoxyeicosatrienoic acids (EETs) are cytochrome P450 (CYP)-dependent eicosanoids that play opposite roles in the regulation of vascular tone, inflammation, and apoptosis. 20-HETE aggravates, whereas E
Externí odkaz:
https://doaj.org/article/bf252068991546c0a8d08f0a533dd4f6
Autor:
Angelika Kusch, Maria Schmidt, Dennis Gürgen, Daniel Postpieszala, Rusan Catar, Björn Hegner, Merci M Davidson, Shokoufeh Mahmoodzadeh, Duska Dragun
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0123385 (2015)
Adaptive cardiac remodeling is characterized by enhanced signaling of mTORC2 downstream kinase Akt. In females, 17ß-estradiol (E2), as well as Akt contribute essentially to sex-related premenopausal cardioprotection. Pharmacologic mTOR targeting wit
Externí odkaz:
https://doaj.org/article/b702964c828e411ea28335a41c8f8772
Autor:
Sara G. Danielli, Ermelinda Porpiglia, Andrea J. De Micheli, Natalia Navarro, Michael J. Zellinger, Ingrid Bechtold, Samanta Kisele, Larissa Volken, Joana G. Marques, Stephanie Kasper, Peter K. Bode, Anton G. Henssen, Dennis Gürgen, Olivier Delattre, Didier Surdez, Josep Roma, Peter Bühlmann, Helen M. Blau, Marco Wachtel, Beat W. Schäfer
Publikováno v:
Science Advances, 9 (6)
Danielli, S G, Porpiglia, E, De Micheli, A J, Navarro, N, Zellinger, M J, Bechtold, I, Kisele, S, Volken, L, Marques, J G, Kasper, S, Bode, P K, Henssen, A G, Gürgen, D, Delattre, O, Surdez, D, Roma, J, Bühlmann, P, Blau, H M, Wachtel, M & Schäfer, B W 2023, ' Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance ', Science Advances, vol. 9, no. 6, eade9238 . https://doi.org/10.1126/sciadv.ade9238
Danielli, S G, Porpiglia, E, De Micheli, A J, Navarro, N, Zellinger, M J, Bechtold, I, Kisele, S, Volken, L, Marques, J G, Kasper, S, Bode, P K, Henssen, A G, Gürgen, D, Delattre, O, Surdez, D, Roma, J, Bühlmann, P, Blau, H M, Wachtel, M & Schäfer, B W 2023, ' Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance ', Science Advances, vol. 9, no. 6, eade9238 . https://doi.org/10.1126/sciadv.ade9238
Rhabdomyosarcoma (RMS) is a group of pediatric cancers with features of developing skeletal muscle. The cellular hierarchy and mechanisms leading to developmental arrest remain elusive. Here, we combined single-cell RNA sequencing, mass cytometry, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f4a878ea2cde7eec5bf8ac9c8637212
https://hdl.handle.net/20.500.11850/598915
https://hdl.handle.net/20.500.11850/598915
Autor:
Fabian Pusch, Heathcliff Dorado García, Robin Xu, Dennis Gürgen, Yi Bei, Lotte Brueckner, Claudia Röefzaad, Jennifer von Stebut, Victor Bardinet, Rocío Chamorro González, Angelika Eggert, Johannes H. Schulte, Patrick Hundsdörfer, Georg Seifert, Kerstin Haase, Beat Schaefer, Marco Wachtel, Anja A. Kühl, Michael V. Ortiz, Antje M. Wengner, Monika Scheer, Anton G. Henssen
The small molecule inhibitor of ataxia telangiectasia and Rad3-related protein (ATR), elimusertib, is currently being tested clinically in various cancer entities in adults and children. Its preclinical anti-tumor activity in pediatric malignancies,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0d29ac49cc5470dd6d6265d1b65580e
https://doi.org/10.1101/2022.11.10.515290
https://doi.org/10.1101/2022.11.10.515290